A possible change in doubling time of haemopoietic progenitor cells with stem cell development.
We separated haemopoietic progenitors derived from marrow cells of 5-fluorouracil (5-FU)-treated mice into three groups, based on the stages of stem cell development and studied doubling time, using a serum-free clonal culture system. Stage I progenitors were those present in primary marrow cells from 5-FU-treated mice. Stages II and III progenitors were early and late progenies in culture of stage I progenitors respectively. The morphological analysis of colonies derived from stage I, II and III progenitors demonstrated an association of progression of stages with loss of multipotentiality. The doubling time of haemopoietic progenitors was estimated by sequential analysis of colony formation and studies of growth fraction. The time required for haemopoietic progenitors to double shortened as their stage of development progressed. Alteration in one doubling time of haemopoietic progenitors at progressive stages of stem cell development was seen in cultures supported by various combinations of growth factors, including interleukin-3 (IL-3), IL-11. and steel factor (SF), Cell-cycle analysis suggested that reduction of the doubling time of haemopoietic progenitors is probably due to a decrease in the time spent in the G1 phase of the cell cycle. Our results suggest that in early haemopoiesis the doubling time of haemopoietic progenitors may change with stem cell development.
Mahmud
N
N
Second Department of Internal Medicine, Mie University School of Medicine, Japan.
Katayama
N
N
Itoh
R
R
Tanaka
R
R
Ohishi
K
K
Masuya
M
M
Mimami
N
N
Shiku
H
H
D000818:Animals; D002453:Cell Cycle; D002455:Cell Division; D002478:Cells, Cultured / Q000166:cytology; D016895:Culture Media, Serum-Free; D004338:Drug Combinations; D005472:Fluorouracil / Q000494:pharmacology*; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D017370:Interleukin-11 / Q000494:pharmacology; D007377:Interleukin-3 / Q000494:pharmacology*; D008297:Male; D051379:Mice; D019089:Stem Cell Factor / Q000494:pharmacology*
D016895:Culture Media, Serum-Free; D004338:Drug Combinations; D017370:Interleukin-11; D007377:Interleukin-3; D019089:Stem Cell Factor; D005472:Fluorouracil